Frazier Financial Advisors, LLC Neurocrine Biosciences Inc Transaction History
Frazier Financial Advisors, LLC
- $122 Billion
- Q1 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 70 shares of NBIX stock, worth $10,198. This represents 0.01% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$10,198
Previous $9.22 Million
4.67%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
94.5MCall Options Held
472KPut Options Held
245K-
Black Rock Inc. New York, NY13.8MShares$2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.45 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$581 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$334 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$328 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...